|
Osmetech plc ("Osmetech") announced today that the AIM-listed international diagnostics group has licensed its proprietary plastic tube technology to Roche Diagnostics, Mannheim Germany . This plastic tube technology was acquired as part of Osmetech's purchase of Molecular Sensing plc.
The worldwide non-exclusive license will enable Roche to develop, manufacture and sell plastic consumable vials for use on its large installed base of LightCycler® instruments as an alternative to existing glass vials.
The same technology has been incorporated into consumables to be supplied for use with Osmetech's Opti GENE instrument scheduled to be exhibited at Medica later this year. The Opti GENE is a fast and easy to use PCR based platform for DNA and RNA analysis.
The terms of the license include an upfront payment to Osmetech plus royalties based upon a percentage of the value of end user sales.
James White, CEO, Osmetech plc said, 'We are delighted that the acquisition of Molecular Sensing has given us this opportunity to create additional revenue before Opti GENE comes to market. Whilst those revenues will initially be modest, we are pleased to be strengthening our relationship further with Roche Diagnostics, one of the world's leading healthcare diagnostics companies.'
For further information:
James White, David Sandilands
Osmetech plc 0207 849 6027
Matthew Moth
madano partnership 44 (207) 378 7033
Notes to editors:
• The Roche LightCycler® is a leading thermal cycler PCR product used throughout the world for DNA and RNA
analysis.
• LightCycler® is a trademark of Roche
• In October 2004, Osmetech acquired OFEX-listed Molecular Sensing plc.
• In April 2003, Osmetech acquired the OPTI product line of blood gas and electrolyte analysers from Roche.
|
